Auriga Reiterates a 'Buy' on Medidata Solutions (MDSO); Q4 Preview
Get Alerts MDSO Hot Sheet
Price: $92.22 --0%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Auriga reiterates a 'Buy' on Medidata Solutions (NASDAQ: MDSO) price target of $33.00.
Auriga analyst said, "While we're anticipating a modest beat, we're trimming our EPS expectations for 2012 due to investment in sales, marketing and innovation as MDSO seeks to exploit new market opportunities. Nonetheless we think the revenue guidance will exceed the consensus view, reassuring investors that the growth story is intact. Expecting modest Q4 beat : Our Q4 estimates are $0.38 on $48MM in revenue, in line with consensus EPS and $1MM above revenue consensus of $47MM. We're comfortable that MDSO meets or beats our estimates."
For an analyst ratings summary and ratings history on Medidata Solutions click here. For more ratings news on Medidata Solutions click here.
Shares of Medidata Solutions closed at $19.98 yesterday.
Auriga analyst said, "While we're anticipating a modest beat, we're trimming our EPS expectations for 2012 due to investment in sales, marketing and innovation as MDSO seeks to exploit new market opportunities. Nonetheless we think the revenue guidance will exceed the consensus view, reassuring investors that the growth story is intact. Expecting modest Q4 beat : Our Q4 estimates are $0.38 on $48MM in revenue, in line with consensus EPS and $1MM above revenue consensus of $47MM. We're comfortable that MDSO meets or beats our estimates."
For an analyst ratings summary and ratings history on Medidata Solutions click here. For more ratings news on Medidata Solutions click here.
Shares of Medidata Solutions closed at $19.98 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amazon.com (AMZN) PT Raised to $215 at UBS
- Can Boeing overcome struggles? Analysts see 'path back to normal' after earnings
- Can Boeing overcome struggles? Analysts see 'path back to normal' after earnings
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
AurigaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!